{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:38:18Z","timestamp":1773977898261,"version":"3.50.1"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Due to coronavirus disease 2019 (COVID-19) pandemic response measures, the administration of botulinum toxin (BTX) was delayed for many patients during the first lockdown period in Portugal.<\/jats:p><jats:p>\n          Objectives\u2003To review the impact of postponing BTX treatment on migraine control.<\/jats:p><jats:p>\n          Methods\u2003This was a retrospective, single-center study. Patients with chronic migraine who had done at least three previous BTX cycles and were considered responders were included. The patients were divided into two groups, one that has had their treatment delayed (group P), and one that has not (controls). The Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) protocol was used. Migraine-related data were obtained at baseline and at three subsequent visits.<\/jats:p><jats:p>\n          Results\u2003The present study included two groups, group P (n\u2009=\u200930; 47.0\u2009\u00b1\u200914.5 years; 27 females, interval baseline -1st visit: 5.5 [4.1\u20135.8] months) and the control group (n\u2009=\u20096; 57.7\u2009\u00b1\u200913.2 years; 6 females; interval baseline\u20131st visit 3.0 [3.0\u20133.2] months). No difference between the groups was present at baseline. When compared to baseline, the number of days\/month with migraine (5 [3\u20136.2] vs. 8 [6\u201315] p\u2009&lt;\u20090.001), days using triptans\/month (2.5 [0\u20136] vs. 3 [0\u20138], p\u2009=\u20090.027) and intensity of pain (7 [5.8\u201310] vs. 9 [7\u201310], p\u2009=\u20090.012) were greater in the first visit for group P, while controls did not present a significant variation. The worsening of migraine-related indicators decreased in the following visits; however, even in the third visit, it had not returned to baseline. Correlations were significant between the delayed time to treatment and the increase in days\/month with migraines at the first visit after lockdown (r\u2009=\u20090.507; p\u2009=\u20090.004).<\/jats:p><jats:p>\n          Conclusions\u2003There was a deterioration of migraine control after postponed treatments, with a direct correlation between the worsening of symptoms and the number of months that the treatment was delayed.<\/jats:p>","DOI":"10.1055\/s-0043-1763490","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T23:57:07Z","timestamp":1681516627000},"page":"248-252","source":"Crossref","is-referenced-by-count":5,"title":["Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic"],"prefix":"10.1055","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9105-018X","authenticated-orcid":false,"given":"Henrique","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio do Porto, Hospital de Santo Ant\u00f3nio, Servi\u00e7o de Neurologia, Porto, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-3449","authenticated-orcid":false,"given":"Gon\u00e7alo","family":"Videira","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio do Porto, Hospital de Santo Ant\u00f3nio, Servi\u00e7o de Neurologia, Porto, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-841X","authenticated-orcid":false,"given":"Sara","family":"Duarte","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio do Porto, Hospital de Santo Ant\u00f3nio, Servi\u00e7o de Neurologia, Porto, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-2121","authenticated-orcid":false,"given":"Carlos","family":"Correia","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio do Porto, Hospital de Santo Ant\u00f3nio, Servi\u00e7o de Neurologia, Porto, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-101X","authenticated-orcid":false,"given":"Carlos","family":"Andrade","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio do Porto, Hospital de Santo Ant\u00f3nio, Servi\u00e7o de Neurologia, Porto, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1007\/s00415-021-10610-w","article-title":"Navigating migraine care through the COVID-19 pandemic: an update","volume":"268","author":"H Angus-Leppan","year":"2021","journal-title":"J Neurol"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"GBD 2016 Headache Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/head.14110","article-title":"Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey study","volume":"61","author":"C C Chiang","year":"2021","journal-title":"Headache"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10194-020-01195-2","article-title":"Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway","volume":"21","author":"E S Kristoffersen","year":"2020","journal-title":"J Headache Pain"},{"issue":"05","key":"ref5","first-page":"291","article-title":"OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection","volume":"35","author":"S Santos-Lasaosa","year":"2020","journal-title":"Neurologia (Engl Ed)"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","article-title":"Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study","volume":"21","author":"J Y Al-Hashel","year":"2020","journal-title":"J Headache Pain"},{"issue":"13","key":"ref7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/0333102420965157","article-title":"Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution","volume":"40","author":"E Caronna","year":"2020","journal-title":"Cephalalgia"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1177\/0333102420965132","article-title":"Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian\/Asiatic flu","volume":"40","author":"T D Rozen","year":"2020","journal-title":"Cephalalgia"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/head.12342","article-title":"Onabotulinumtoxin [corrected] A (Botox)","volume":"54","author":"D Tepper","year":"2014","journal-title":"Headache"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10072-020-04940-2","article-title":"Impact of COVID-19 on neurological patients attending a botulinum toxin service","volume":"42","author":"R Erro","year":"2021","journal-title":"Neurol Sci"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1007\/s10072-021-05180-8","article-title":"Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown","volume":"42","author":"A Gonzalez-Martinez","year":"2021","journal-title":"Neurol Sci"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/head.13880","article-title":"Should We Adapt the Prescription Criteria for Specific Treatments for Migraine Due to the COVID-19 Pandemic?","volume":"60","author":"J Porta-Etessam","year":"2020","journal-title":"Headache"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/head.13830","article-title":"Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus Hotspot","volume":"60","author":"A Ali","year":"2020","journal-title":"Headache"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1763490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T23:57:59Z","timestamp":1681516679000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1763490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":13,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,4,14]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1763490","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}